pyrimidine dimers has been researched along with Acute Myelogenous Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanawalt, PC; Hsu, PH; Nouspikel, T | 1 |
| Chao, YB; Fernandez, JA; Griffin, JH; Hartman, DL; Helterbrand, J; Mesters, RM; Utterback, BG; Yan, B | 1 |
2 other study(ies) available for pyrimidine dimers and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Nucleotide excision repair phenotype of human acute myeloid leukemia cell lines at various stages of differentiation.
Topics: Antineoplastic Agents; Base Sequence; Cell Differentiation; Cell Line, Tumor; Cisplatin; DNA Adducts; DNA Damage; DNA Repair; DNA, Neoplasm; Gene Expression; Genes, p53; Humans; Leukemia, Myeloid, Acute; Phenotype; Pyrimidine Dimers | 2007 |
Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications.
Topics: Antineoplastic Agents; Enzyme-Linked Immunosorbent Assay; Humans; Intensive Care Units; Leukemia, Myeloid, Acute; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Prospective Studies; Protein C; Pyrimidine Dimers; Sepsis; Shock, Septic | 2000 |